Yuflyma and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Yuflyma (adalimumab-aaty), especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years also take Methotrexate, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Joint pain when taking Yuflyma. It is created by eHealthMe based on reports of 340 people who have side effects when taking Yuflyma from the FDA, and is updated regularly.

What is Yuflyma?

Yuflyma has active ingredients of adalimumab-aaty. eHealthMe is studying from 341 Yuflyma users. Check the latest studies of Yuflyma.

What is Joint pain?

Joint pain is found to be associated with 3,330 drugs and 5,207 conditions by eHealthMe. Check the latest studies of Joint pain.

On Jul, 20, 2026

340 people reported to have side effects when taking Yuflyma.
Among them, 71 people (20.88%) have Joint pain.

Among these 71 people:

How long have people been on Yuflyma when they have Joint pain? *

What is the gender of people who have Joint pain when taking Yuflyma? *

female: 70.59 %
male: 29.41 %

What is the age of people who have Joint pain when taking Yuflyma? *

What are other drugs people take besides Yuflyma? *

What are other side effects people have besides Joint pain? *

Pain In Extremity: 35 people, 49.30%
Fatigue (feeling of tiredness): 32 people, 45.07%
Drug Ineffective: 31 people, 43.66%
Headache (pain in head): 24 people, 33.80%
Back Pain: 23 people, 32.39%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 21 people, 29.58%
Joint Stiffness: 17 people, 23.94%
Itching: 17 people, 23.94%
Pain: 17 people, 23.94%
Nasopharyngitis (inflammation of the nasopharynx): 16 people, 22.54%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 35 people, 49.30%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 18 people, 25.35%
Ankylosing Spondylitis (type of arthritis affecting the spine): 17 people, 23.94%
Psoriasis (immune-mediated disease that affects the skin): 7 people, 9.86%
Pain: 4 people, 5.63%
Indigestion: 4 people, 5.63%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 2.82%
Inflammatory Bowel Disease: 2 people, 2.82%
Diabetes: 2 people, 2.82%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 2.82%

* Approximation only. Some reports may have incomplete information.

Do you take Yuflyma and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Yuflyma:

Yuflyma (341 reports)

Joint pain treatments and more:

Joint pain (542,934 reports)

Browse all side effects of Yuflyma:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,330 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,207 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab-aaty (the active ingredients of Yuflyma) and Yuflyma (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.